The House Ways and Means Committee on Tuesday approved the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113), AHA-supported legislation that would increase transparency with regard to prescription drug pricing. 
  
"As it considers this legislation, we want to commend the Committee for including several policies that will better hold drug manufacturers accountable," AHA said in a letter of support for the bill. 
  
Specifically, AHA applauded the inclusion of the Reporting Accurate Drug Prices Act, which would require all manufacturers to submit pricing data to the Department of Health and Human Services; and the SPIKE Act, which would require drug companies to provide written justification for new drugs with high launch prices or existing drugs with excessive price increases over certain time periods. AHA also voiced support for provisions that would make publicly available the total amount and value of the free samples drug manufacturers provide to patients. 
  
"While the AHA understands the assistance that free drug samples can provide for patients who need them, especially those individuals with limited financial flexibility, we are concerned that these samples may improperly incentivize patients and providers to use and prescribe certain drugs," the association said.

Related News Articles

Headline
The AHA today voiced support for the Recovering Excessive Funds for Unused and Needless Drugs Act (S. 551), legislation that would incentivize manufacturers to…
Headline
Idaho Gov. Brad Little this week signed legislation adding work requirements to the state’s plan to expand Medicaid coverage to low-income adults.
Headline
Sen. Bernie Sanders, I-Vt., and 14 of his Democratic colleagues today introduced the Medicare for All Act of 2019, legislation that would create a national…
Headline
Reps. Earl Blumenauer, D-Ore., and Markwayne Mullin, R-Okla., yesterday reintroduced  the Overdose Prevention and Patient Safety Act (H.R. 2062), AHA-supported…
Headline
The House Committee on Energy and Commerce yesterday passed a number of AHA-supported bills that would lower prescription drug costs and strengthen the…
Headline
The AHA expressed support for a number of bills being considered today by the House Committee on Energy and Commerce that would lower prescription drug costs…